11

The study will make use of an app to determine whether the Apple Watch’s heart-rate sensor can help detect a heart condition known as atrial fibrillation.

New discoveries about the circadian-clock machinery in the precursors to fat cells may explain why shift workers are prone to metabolic diseases, such as diabetes, a Stanford study finds.

CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.

Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.

Mike Alvarez, the animal care supervisor in the Veterinary Service Center, received the 2017 Marsh O’Neill award. The award is one of the few opportunities for faculty to acknowledge publicly the support of outstanding staff members who support their research activity.

Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.

The magazine’s fall issue highlights the ways specialists are using the latest technology and treatments to put children and their families at the center of care. It also includes an inside peek at the new Packard Children’s Hospital.

A series of fortunate events eventually brought successful medical device entrepreneur Milt McColl, MD, back to his original mission — clinical medicine.

Under the new guidelines, tens of millions more Americans now meet the criteria for having high blood pressure.

The event was an opportunity for employees to learn more about the financial state of the School of Medicine, as well as to ask questions about it.